Healthcare

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

03 Apr 2018  |  Asia Pacific  |  Market Outlook

Asia-Pacific Healthcare Outlook, 2018

The Year of Digital Innovation in Asia-Pacific

Infographics

×

The healthcare industry in Asia-Pacific (APAC) is expected to grow at 12.5% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care out...

16 Feb 2018  |  Europe  |  Market Research

Poland’s New Business Models in Medical Imaging, Forecast to 2021

A Change of Course in Polish Healthcare Policy May Disrupt Conventional Public-Private Working Models

Infographics

×

This research study focuses on the drive to operationalize capital and service costs favoring non-conventional business models (MES and MVS) in Poland over traditional capital-intensive purchasing and service models. The study also features a detailed elaboration on the legacy of public-private partnerships (PPP), framework agreement case studies, ...

Healthcare expenditure in Malaysia is growing at a higher rate than the expenditure per capita, which translates into better healthcare provision and quality of service in the country. The Malaysian endoscopy devices market is growing under budget constraints that are forcing hospitals to focus on equipment pricing, negotiate better prices, opt fo...

The Indonesian endoscopy devices market is growing. It is driven by rising awareness, the growing demand for better healthcare, and the expanding aging population. Growth is also attributed to the increase in the number of patients and treatment procedures and the anticipated rise in the number of minimally invasive surgeries. The introduction o...

Japan’s healthcare system is an icon of kindness and compassion. The country spends 11.4% of its gross domestic product (GDP) on healthcare, which equates to just over $560 billion or about one-fifth of the healthcare spending by the United States (US). At that level of spending, the Japanese people enjoy universal health coverage, affordable hea...

10 Jan 2018  |  Asia Pacific  |  Mega Trends

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...